BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 23537975)

  • 21. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.
    González-Costello J; Comín-Colet J; Lupón J; Enjuanes C; de Antonio M; Fuentes L; Moliner-Borja P; Farré N; Zamora E; Manito N; Pujol R; Bayés-Genis A
    BMC Cardiovasc Disord; 2018 Nov; 18(1):206. PubMed ID: 30382817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
    Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
    Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.
    Enjuanes C; Klip IT; Bruguera J; Cladellas M; Ponikowski P; Banasiak W; van Veldhuisen DJ; van der Meer P; Jankowska EA; Comín-Colet J
    Int J Cardiol; 2014 Jun; 174(2):268-75. PubMed ID: 24768464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
    Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.
    Baggish AL; van Kimmenade R; Bayes-Genis A; Davis M; Lainchbury JG; Frampton C; Pinto Y; Richards MA; Januzzi JL
    Clin Chim Acta; 2007 Jun; 381(2):145-50. PubMed ID: 17445789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, prognostic importance and therapeutic implications of anemia in heart failure.
    Mishra TK; Mishra SK; Mohanty NK; Rath PK
    Indian Heart J; 2005; 57(6):670-4. PubMed ID: 16521636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.
    González-Costello J; Comín-Colet J
    Eur J Heart Fail; 2010 Nov; 12(11):1159-62. PubMed ID: 20855375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and spectrum of iron deficiency in heart failure patients in south Rajasthan.
    Sharma SK; Agarwal SK; Bhargava K; Sharma M; Chopra K; Arumugam G
    Indian Heart J; 2016; 68(4):493-7. PubMed ID: 27543471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure.
    Bonaque JC; Pascual-Figal DA; Manzano-Fernández S; González-Cánovas C; Vidal A; Muñoz-Esparza C; Garrido IP; Pastor-Pérez F; Valdés M
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):606-12. PubMed ID: 22440296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
    Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
    Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron deficiency: an emerging therapeutic target in heart failure.
    Cohen-Solal A; Leclercq C; Deray G; Lasocki S; Zambrowski JJ; Mebazaa A; de Groote P; Damy T; Galinier M
    Heart; 2014 Sep; 100(18):1414-20. PubMed ID: 24957529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applicability of new proposed criteria for iron deficiency in Japanese patients with heart failure.
    Tada A; Nagai T; Koya T; Nakao M; Ishizaka S; Mizuguchi Y; Aoyagi H; Imagawa S; Tokuda Y; Takahashi M; Kato Y; Machida M; Matsutani K; Saito T; Anzai T;
    ESC Heart Fail; 2023 Apr; 10(2):985-994. PubMed ID: 36495060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron deficiency and hematinic deficiencies in atrial fibrillation: A new insight into comorbidities.
    Keskin M; Ural D; Altay S; Argan O; Börklü EB; Kozan Ö
    Turk Kardiyol Dern Ars; 2018 Mar; 46(2):103-110. PubMed ID: 29512626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
    Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
    Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.